Novel receptor interaction and repression domains in the orphan receptor SHP

SHP (short heterodimer partner) is a novel orphan receptor that lacks a conventional DNA binding domain and interacts with other members of the nuclear hormone receptor superfamily. We have characterized the SHP sequences required for interaction with other superfamily members, and have defined an SHP repressor domain. In the mammalian two-hybrid system, a fusion of full-length SHP to the GAL4 DNA binding domain shows 9-cis-retinoic acid-dependent interaction with a VP16-retinoid X receptor alpha (RXR alpha) fusion. By deletion analysis, sequences required for this RXR interaction map to the central portion of SHP (amino acids 92 to 148). The same region is required for interaction with RXR in vitro and in the yeast two-hybrid system, and results from the yeast system suggest that the same SHP sequences are required for interaction with other members of the nuclear hormone receptor superfamily such as thyroid hormone receptor and retinoic acid receptor. In mammalian cells, a GAL4-SHP fusion protein shows about 10-fold-decreased transcriptional activation relative to GAL4 alone, and fusion of SHP to the C terminus of a GAL4-VP16 fusion to generate a triple chimera also results in a strong decrease in transactivation activity. Sequences required for this repressor function were mapped to the C terminus of SHP. This region is distinct from that required for corepressor interaction by other members of the nuclear hormone receptor superfamily, and SHP did not interact with N-CoR in either the yeast or mammalian two-hybrid system. Together, these results identify novel receptor interaction and repressor domains in SHP and suggest two distinct mechanisms for inhibition of receptor signaling pathways by SHP.

[1]  B. Raaka,et al.  Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor , 1994, Molecular and cellular biology.

[2]  M. Vidal,et al.  RPD3 encodes a second factor required to achieve maximum positive and negative transcriptional states in Saccharomyces cerevisiae , 1991, Molecular and cellular biology.

[3]  G. Tong,et al.  Ligand Modulates the Interaction of Thyroid Hormone Receptor with the Basal Transcription Machinery (*) , 1995, The Journal of Biological Chemistry.

[4]  William Bourguet,et al.  A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[5]  D. Moore,et al.  An Orphan Nuclear Hormone Receptor That Lacks a DNA Binding Domain and Heterodimerizes with Other Receptors , 1996, Science.

[6]  M. Ito,et al.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.

[7]  M. Privalsky,et al.  Identification of TRACs (T3 receptor-associating cofactors), a family of cofactors that associate with, and modulate the activity of, nuclear hormone receptors. , 1996, Molecular endocrinology.

[8]  M. Downes,et al.  Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. , 1996, Nucleic acids research.

[9]  D. Landsman,et al.  Requirement of a corepressor for Dr1-mediated repression of transcription. , 1996, Genes & development.

[10]  D. Reinberg,et al.  Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription , 1992, Cell.

[11]  S. Fawell,et al.  A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor , 1990, Molecular and cellular biology.

[12]  Roger Brent,et al.  C dil, a Human Gl and S Phase Protein Phosphatase That Associates with Cdk2 , 2003 .

[13]  A. Wolffe.  Transcriptional control. Sinful repression. , 1997, Nature.

[14]  S. Fawell,et al.  Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor , 1990, Cell.

[15]  K. Umesono,et al.  Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. , 1996, Molecular endocrinology.

[16]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[17]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[18]  A. Cooney,et al.  Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. , 1994, Molecular endocrinology.

[19]  H. Samuels,et al.  Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. , 1990, Molecular endocrinology.

[20]  William Bourguet,et al.  Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.

[21]  A. Wolffe.  Sinful repression , 1997, nature.

[22]  Philippe Kastner,et al.  Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.

[23]  D. Moore,et al.  Human growth hormone as a reporter gene in regulation studies employing transient gene expression , 1986, Molecular and cellular biology.

[24]  D. Moore,et al.  Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. , 1996, Molecular endocrinology.

[25]  A. Monaco,et al.  An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.

[26]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[27]  A. Wolffe,et al.  Histone acetyltransferases in control. , 1997, Current biology : CB.

[28]  D. Moore,et al.  A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements , 1994, Molecular and cellular biology.

[29]  H. Stunnenberg,et al.  9-cis retinoic acid signaling: changing partners causes some excitement. , 1995, Genes & development.

[30]  B M Raaka,et al.  The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation , 1995, Molecular and cellular biology.

[31]  M. Downes,et al.  Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. , 1996, Nucleic acids research.

[32]  R. Evans,et al.  Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. , 1994, Genes & development.

[33]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[34]  D. Moore,et al.  Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. , 1995, Molecular endocrinology.

[35]  M. Pazin,et al.  What's Up and Down with Histone Deacetylation and Transcription? , 1997, Cell.

[36]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[37]  R. Roeder,et al.  Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression , 1996, Molecular and cellular biology.

[38]  M. Lazar,et al.  Stoichiometric and steric principles governing repression by nuclear hormone receptors. , 1997, Genes & development.

[39]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[40]  R. Brent,et al.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. , 1995, Molecular endocrinology.

[41]  B. O’Malley,et al.  Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). , 1997, Molecular endocrinology.

[42]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[43]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[44]  H. Samuels,et al.  A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. , 1989, Molecular endocrinology.